---
authors: 
- admin
categories: []
date: "2019-12-11T09:00:00Z"
slides:
  highlight_style: dracula
  theme: black
summary: Slides for CUMC Resident Lecture 12-13-19.
tags: 
- Education
- Melanoma
- Dermatology
- Medical Oncology
title: Melanoma - Pathogenesis, Diagnosis and Work Up
project:
- Clinical Educator  
---

{{< slide background-image="./Slides/Intro-Slide.jpg" >}}

---

{{< slide background-image="./Slides/Disclosures.jpg" >}}  

---

## Learning Objectives

- Review basic epidemiology of melanoma
- Review molecular mechanisms of melanoma
- Discuss risk factors for melanoma
- Review how to evaluate and stage patients
- Overview of management of melanoma

---

## Pre-Lecture Quiz

- Take out your cell phone
- Open text message app
- Follow the instructions on the screen

---

## Epidemiology

- 1:25 Americans will get some kind of melanoma in their lifetime
- 1:52 Americans will get an invasive melanoma in their lifetime
- Estimated to be 96,480 newly diagnosed cases of invasive melanoma in the U.S. in 2019
  - 95,830 cases of melanoma in situ 
- Between 9,000-10,000 deaths annually


---

{{< slide background-image="./Slides/ACS-Cancer-Stats.jpg" >}}  

---

## Hallmarks of Cancer

- Self-sufficiency of growth signals
- Insensitivity to anti-growth signals
- Evading apoptosis
- Limitless replicative potential
- Sustained angiogenesis
- Tissue invasion and metastasis  

Ref: Hanahan and Weinberg. *Cell* 2000. Vol 100

---


### Hallmarks of Cancer - Updated

- Deregulating Cellular Energetics
- Genome Instability and Mutation
- Avoiding Immune Destruction
- Tumor-promoting Inflammation

Ref: Hanahan and Weinberg. *Cell* 2011.

---


## Melanoma Pathogenesis

---

### Oncogenes and Tumor Suppressors

---

{{< slide background-image="./Slides/Oncogenes-tsgs.jpg" >}}

---

## Oncogenes in Melanoma


---

{{< slide background-image="./Slides/Oncogenes-in-melanoma.jpg" >}}

---

{{< slide background-image="./Slides/cell-cycle.jpg" >}}

---

{{< slide background-image="./Slides/legend-cell-cycle.jpg" >}} 

---

{{< slide background-image="./Slides/senescence.jpg" >}} 

#### Oncogene-Induced Senescence

--- 

{{< slide background-image="./Slides/legend-senescence.jpg" >}} 

---

## Why don’t all melanocytes undergo oncogene-induced senescence?

---

{{< slide background-image="./Slides/cell-cycle-2.jpg" >}} 

---

{{< slide background-image="./Slides/melanoma-pathways.jpg" >}}
  
---

{{< slide background-image="./Slides/melanoma-pathways-legend.jpg" >}}

--- 

## Risk Factors for Melanoma - Genetics

---

## Susceptibility to Cutaneous Malignant Melanoma (CMM)

- There are numerous loci that have been identified that predispose patients to melanoma
Several familial syndromes have been described
  - E.g. in 1978, Clark et al pointed out distinctive clinical and histologic features of the moles that are precursors of familial malignant melanomas
  
---

## CMM - BK Mole Syndrome

- B-K Mole Syndrome (named after family names of 2 of the patients)
    + Aka FAMMM (Familial Atypical Mole-malignant Melanoma)
- Penetrance
  - 58% to 92% by 80 years of age and varies with geography

---
### CMM Genetics
- CMM1 has been mapped to chromosome 1p36. 
- CMM2 – CDKN2A (9p21)
- CMM3 – CDK4 (12q14)
- CMM4 – mapped to chromosome 1p22
- CMM5 – MC1R (16q24)
- CMM6 – XRCC3 (14q32) 
- CMM7 – mapped to chromosome 20q11 
- CMM8 – MITF (3p13)
- CMM9 – TERT (5p15)
- CMM10 – POT1 (7q31) 

---

{{< slide background-image="./Slides/CMM-Somatic.jpg" >}}
Predominantly Somatic Mutations in Purple


---
 

{{< slide background-image="./Slides/CMM-inherited.jpg" >}}

CMM Mutations in Yellow

---

  {{< slide background-image="./Slides/RFs-environment.jpg" >}}
  
---  

  {{< slide background-image="./Slides/RFs-genotype.jpg" >}}

---

{{< slide background-image="./Slides/Risk-atypical-nevi.jpg" >}}

---

{{< slide background-image="./Slides/Risk-nevi.jpg" >}}

---

{{< slide background-image="./Slides/Right-arm.jpg" >}}

---

{{< slide background-image="./Slides/Types-Melanoma.jpg" >}}

---

{{< slide background-image="./Slides/SSM.jpg" >}}

---


{{< slide background-image="./Slides/Nodular-Melanoma.jpg" >}}

---


{{< slide background-image="./Slides/Lentigo-Maligna.jpg" >}}

---


{{< slide background-image="./Slides/ALM.jpg" >}}

---


{{< slide background-image="./Slides/Desmoplastic.jpg" >}}

---


{{< slide background-image="./Slides/Desmoplastic-2.jpg" >}}

---

## Diagnosis and Work Up

---

## Biopsy

-  Ideally, a patient with a lesion suspicious for melanoma should have
a narrow excisional biopsy
- This biopsy can be performed with a variety of techniques 
  - Elliptical excision
  - Punch biopsy
  - Saucerization 
  
---

{{< slide background-image="./Slides/Biopsy-technique.jpg" >}}

---

{{< slide background-image="./Slides/transection-evidence.jpg" >}}

---

{{< slide background-image="./Slides/gen-mgmt-pt-melanoma.jpg" >}}

---

{{< slide background-image="./Slides/Tx-strategies.jpg" >}}

---

{{< slide background-image="./Slides/Approved-Tx.jpg" >}}

---
  
{{< slide background-image="./Slides/CIT.jpg" >}}
   
  
---

{{< slide background-image="./Slides/Legend-CIT.jpg" >}} 

---

{{< slide background-image="./Slides/Stage-3-Tx.jpg" >}}

---

{{< slide background-image="./Slides/Tx-Metastatic-Dz.jpg" >}}

---
